JPH0225406Y2 - - Google Patents

Info

Publication number

JPH0225406Y2

JPH0225406Y2 JP18308985U JP18308985U JPH0225406Y2 JP H0225406 Y2 JPH0225406 Y2 JP H0225406Y2 JP 18308985 U JP18308985 U JP 18308985U JP 18308985 U JP18308985 U JP 18308985U JP H0225406 Y2 JPH0225406 Y2 JP H0225406Y2

Authority

JP

Japan

Prior art keywords

membrane module

molecular weight

blood

plasma

replacement fluid

Prior art date

1985-11-27

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Expired

Links

• Espacenet
• Global Dossier
• Discuss

• 239000012528 membrane Substances 0.000 claims description 48
• 210000004369 blood Anatomy 0.000 claims description 33
• 239000008280 blood Substances 0.000 claims description 33
• 239000012530 fluid Substances 0.000 claims description 28
• 239000000126 substance Substances 0.000 claims description 26
• 210000000601 blood cell Anatomy 0.000 claims description 9
• 238000009795 derivation Methods 0.000 description 5
• 238000000926 separation method Methods 0.000 description 5
• 230000004872 arterial blood pressure Effects 0.000 description 3
• 239000012510 hollow fiber Substances 0.000 description 3
• 230000037452 priming Effects 0.000 description 3
• 102000009027 Albumins Human genes 0.000 description 2
• 108010088751 Albumins Proteins 0.000 description 2
• 229920000219 Ethylene vinyl alcohol Polymers 0.000 description 2
• HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
• 239000004372 Polyvinyl alcohol Substances 0.000 description 2
• 229920001577 copolymer Polymers 0.000 description 2
• 230000000694 effects Effects 0.000 description 2
• 239000004715 ethylene vinyl alcohol Substances 0.000 description 2
• 229960002897 heparin Drugs 0.000 description 2
• 229920000669 heparin Polymers 0.000 description 2
• RZXDTJIXPSCHCI-UHFFFAOYSA-N hexa-1,5-diene-2,5-diol Chemical compound OC(=C)CCC(O)=C RZXDTJIXPSCHCI-UHFFFAOYSA-N 0.000 description 2
• 238000001990 intravenous administration Methods 0.000 description 2
• 229920002451 polyvinyl alcohol Polymers 0.000 description 2
• 238000004140 cleaning Methods 0.000 description 1
• 230000001112 coagulating effect Effects 0.000 description 1
• 238000007796 conventional method Methods 0.000 description 1
• 230000001934 delay Effects 0.000 description 1
• 239000007788 liquid Substances 0.000 description 1
• 238000000034 method Methods 0.000 description 1
• 239000013589 supplement Substances 0.000 description 1
• 238000011144 upstream manufacturing Methods 0.000 description 1